Member Login
Search
Event Calendar
Prev MonthPrev Month Next MonthNext Month
Ketamine in Patients With Substance Use Disorders
Wednesday, October 15, 2025, 7:00 PM EST
Category: Events

Ketamine and Substance Use Disorders: Clinical Boundaries and Emerging Therapies

Join the NYCPS Addiction Committee for an interactive panel discussion exploring the complex intersection of ketamine and substance use disorders (SUDs). Clinical and research experts will examine two key questions: Is it appropriate to use ketamine for patients with co-occurring SUDs, and what is the current evidence for ketamine as a treatment for SUDs themselves? The session will feature a dynamic exchange of perspectives, audience Q&A, and practical insights for clinicians and researchers. All NYCPS members are welcome—bring your questions and join the conversation.

This event is FREE for APA Members & Med-Students
Non-APA Members: $35
Dr. Daniel Zimmerman is a clinical instructor at NYU Grossman School of medicine, and is the co-founder of Acheron Psychiatry. Dr. Zimmerman specializes in general psychiatry, psychotherapy, and psychedelic-assisted therapy, including Ketamine-Assisted Psychotherapy (KAP). He completed his psychiatry residency at Harvard MGH-McLean, followed by a Public Psychiatry Fellowship at NYU/Bellevue. 
Dr. Mashal Khan is an Assistant Professor of Clinical Psychiatry at Weill Cornell Medicine and the Associate Program Director for the Addiction Psychiatry Fellowship. He completed psychiatry residency at Maimonides Medical Center, and an Addiction Psychiatry Fellowship at Mount Sinai West. His area of interest and clinical focus include technology-assisted interventions for substance use disorders and management of alcohol use disorder in patients with alcohol liver disease. Dr. Khan has recently contributed and served as editor for two books, titled "Technology-Assisted Interventions for Substance Use Disorders" and "From Stigma to Support: A New Vision for Alcohol Use Disorder Treatment and Recovery". 
Dr. Amy Swift is the Deputy Chief Medical Officer of Silver Hill Hospital, where she oversees many services on the campus with special attention to the inpatient services. She completed her psychiatry residency and addiction psychiatry fellowship at Mount Sinai Beth Israel. She is the former Medical Director of Addiction Services at Mount Sinai Beth Israel and former Program Director of their Addiction Psychiatry Fellowship.
Dr. Diana Martinez is a distinguished psychiatric researcher specializing in addiction at Columbia University/New York State Psychiatric Institute, where she is a Professor of Psychiatry. Dr. Martinez completed her psychiatry residency at New York-Presbyterian/Weill Cornell Medical Center. Her current research includes studying the role of neuromodulation in the treatment of substance use disorders.